Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2
Description
Current vaccine efforts to combat SARS-CoV-2 are focused on the whole spike protein administered as mRNA, viral vector, or protein subunit. However, the SARS-CoV-2 receptor-binding domain (RBD) is the immunodominant portion of the spike protein
